Skip to main content
Log in

A new report of triclabendazole efficacy during invading phase fasciolasis

  • Letters
  • Published:
European Journal of Clinical Microbiology and Infectious Diseases Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Loutan L, Bouvier M, Rojanawisut B, Stadler H, Rouan MC, Buescher G, Poltera AA: Single treatment of invasive fasciolasis with triclabendazole. Lancet 1989, i: 383.

    Article  Google Scholar 

  2. Markwalder K, Koller M, Goebel N, Wolff K: Infektion mitFasciola hepatica. Schweizerische medizinische Wochenschrift 1988, 118: 1048–1152.

    PubMed  Google Scholar 

  3. Coles GC: Antihelminthic activity of triclabendazole. Journal of Helminthology 1986, 60: 210–212.

    PubMed  Google Scholar 

  4. Rapic D, Dzakula N, Sakar D, Richards RJ: Comparative efficacy of triclabendazole, nitroxymil and rafoxanide against immature and matureFasciola hepatica in naturally infected cattle. Veterinary Record 1988, 112: 59–62.

    Google Scholar 

  5. Wessely D, Reischig HL, Heinerman M, Stempka R: Human fasciolasis treated with triclabendazole (Fasinex) for the first time. Transactions of the Royal Society of Tropical Medicine & Hygiene 1988, 82: 743–745.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Picot, S., Querrec, M., Ghez, J.L. et al. A new report of triclabendazole efficacy during invading phase fasciolasis. Eur. J. Clin. Microbiol. Infect. Dis. 11, 269–270 (1992). https://doi.org/10.1007/BF02098098

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02098098

Keywords

Navigation